However, some studies have found that Beclin-1 is expressed at low levels in bladder cancer (30), salivary gland adenoid cystic carcinoma (31), and pancreatic ductal adenocarcinoma (32) and that patients with low Beclin-1 expression have shorter survival times. The gene discussed is BECN1; the disease is salivary gland adenoid cystic carcinoma.